ZNTL·98943L107·US·equity·Healthcare - Biotechnology-Activist
ZNTL (ZENTALIS PHARMACEUTICALS INC) is held by 56 institutional investors as of Q1 2026. Largest holders: TWO SIGMA INVESTMENTS, LP ($6.9M), RENAISSANCE TECHNOLOGIES LLC ($4.5M), CITADEL ADVISORS LLC ($4.1M). Net institutional sentiment: Mixed.
See how ZNTL's score breaks down across 4 SEC sources
Showing 1-20 of 60
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer